Company profile
UK company 13415161, incorporated on 24 May 2021.
Epilepsygtx Limited is a UK company with status active founded in 2021 based in South East England.
Company number 13415161
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
CERTNM | Transaction MzU0NjIyMjU3MmFkaXF6a2N4
Published 22 Sep 2026 09:14
AA | Transaction MzU0MTkzOTQ5MGFkaXF6a2N4 | Paper/PDF filed
Published 09 Sep 2026 00:53
Company registered at Companies House
Epilepsygtx develops gene therapy for refractory epilepsy.
This is a new spinout building on our Gene therapy expertise. It was established by founders and is in the process of singing of legal documents for an initial investment from UCL Tech fund. It will have the potential to licence IP developed from this award, and benefits from our experience developing gene therapy tools.
$10M Series A raise
The company is just set up. The impact will be to consolidate a portfolio of gene therapy approaches to treat refractory epilepsy and to deliver clinical trails.
The company has supported CTA-enabling toxicity, biodistribution and efficacy studies, and is in the process of raising a Series A investment to commission manufacture of a batch of clinical grade viral vector and submit a CTA application.
